Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

8P1X

TarM(Se)_G117R-UDP-glucose

This is a non-PDB format compatible entry.
Summary for 8P1X
Entry DOI10.2210/pdb8p1x/pdb
DescriptorTarM(Se), CHLORIDE ION, PHOSPHATE ION, ... (8 entities in total)
Functional Keywordsstaphylococcus epidermidis, glycosyltransferase, gt-b fold, alpha-o-glucose, wall teichoic acid, transferase
Biological sourceStaphylococcus epidermidis
Total number of polymer chains1
Total formula weight61016.54
Authors
Guo, Y.,Stehle, T. (deposition date: 2023-05-13, release date: 2023-12-06)
Primary citationGuo, Y.,Du, X.,Krusche, J.,Beck, C.,Ali, S.,Walter, A.,Winstel, V.,Mayer, C.,Codee, J.D.C.,Peschel, A.,Stehle, T.
Invasive Staphylococcus epidermidis uses a unique processive wall teichoic acid glycosyltransferase to evade immune recognition.
Sci Adv, 9:eadj2641-eadj2641, 2023
Cited by
PubMed Abstract: expresses glycerol phosphate wall teichoic acid (WTA), but some health care-associated methicillin-resistant (HA-MRSE) clones produce a second, ribitol phosphate (RboP) WTA, resembling that of the aggressive pathogen . RboP-WTA promotes HA-MRSE persistence and virulence in bloodstream infections. We report here that the TarM enzyme of HA-MRSE [TarM(Se)] glycosylates RboP-WTA with glucose, instead of -acetylglucosamine (GlcNAc) by TarM(Sa) in . Replacement of GlcNAc with glucose in RboP-WTA impairs HA-MRSE detection by human immunoglobulin G, which may contribute to the immune-evasion capacities of many invasive . Crystal structures of complexes with uridine diphosphate glucose (UDP-glucose), and with UDP and glycosylated poly(RboP), reveal the binding mode and glycosylation mechanism of this enzyme and explain why TarM(Se) and TarM(Sa) link different sugars to poly(RboP). These structural data provide evidence that TarM(Se) is a processive WTA glycosyltransferase. Our study will support the targeted inhibition of TarM enzymes, and the development of RboP-WTA targeting vaccines and phage therapies.
PubMed: 38000019
DOI: 10.1126/sciadv.adj2641
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.03 Å)
Structure validation

226707

數據於2024-10-30公開中

PDB statisticsPDBj update infoContact PDBjnumon